• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors




Dane R. Boyington, PhD

Latest:

Improving Medication Understanding Among Latinos Through Illustrated Medication Lists

A randomized controlled trial found that plain-language, illustrated medication lists improved medication understanding among Latinos.





John J. Sheehan, PhD, RPh

Latest:

Quality Measure Improvement Strategies for Elderly Patients With Diabetes

The authors discuss a simple strategy for payers to ensure more patients with type 2 diabetes achieve control of A1C.


Peter M. Wahl, BA

Latest:

Burden of Alzheimer's Disease and Association With Negative Health Outcomes

Community-based persons with Alzheimer’s disease have a higher risk of fractures, hospitalization, and various comorbidities than persons without the disease.



Risto Huupponen, MD, PhD

Latest:

Pattern of Statin Use Among 10 Cohorts of New Users From 1995 to 2004: A Register-Based Nationwide Study

One-year persistence among new users of statins in Finland improved from 1995 to 1998, after which no substantial changes were observed up to 2004.



Sherry M. Wren, MD

Latest:

Geographic Variation in Surgical Outcomes and Cost Between the United States and Japan

Compared with Japan, the United States has substantially less geographic variation in surgical outcomes, but it has higher variation in cost.


Michael Kolodjiez, MD

Latest:

Discussion 6: Next‐Generation Genetic Sequencing in Oncology: Ready for Prime Time?

Mr Klein leads another discussion with Michael Kolodjiez, MD, Lee N. Newcomer, MD, MHA, John L. Fox, MD, MHA, and Jerry Conway. The panel responds to whether there are gaps in targeted gene analyses. They also discuss other issues including bioinformatics, and how payers, providers, and pharmacists might collaborate on improving care through genetic sequencing.


John Chen, PhD

Latest:

Healthcare Network Analysis of Patients With Diabetes and Their Physicians

Network analyses of patients with diabetes in Hawaii illustrate structures and links that health plans could leverage to strengthen quality improvement and disease management programs.




Kurt Kroenke, MD

Latest:

Benzodiazepine and Unhealthy Alcohol Use Among Adult Outpatients

Among outpatients who were screened for alcohol use, those with unhealthy alcohol use, women, and those who were older, white, and of lower socioeconomic status were more likely to use benzodiazepines.


Kristi Reynolds, PhD, MPH

Latest:

Patient and Physician Perceptions of a Hypercholesterolemia Safety-Net Program

Patients’ misperceptions of statins and physicians’ limited knowledge of a hypercholesterolemia safety-net program warrant additional interventions to reduce barriers and improve care.


Gary P. Gilmore, RPh

Latest:

Prescription Opioid Abuse: Challenges and Opportunities for Payers

This article outlines strategies insurers can use to mitigate their risks related to prescription opioid abuse by members, while addressing this serious public health problem.



Niyati Nathwani, MD

Latest:

Addressing Cancer Health Disparities in a Multilateral Collaboration in an Independent Community Cancer Clinic: Translating Words Into Action

No One Left Behind, a program to provide financial assistance and access to cancer care at Carolina Blood and Cancer Care Associates in South Carolina, will be discussed during a session of the Community Oncology Alliance 2022 Community Oncology Conference.


Zachary Burningham, PhD

Latest:

VA Geriatric Scholars Program’s Impact on Prescribing Potentially Inappropriate Medications

Primary care teams reduced their prescribing of potentially inappropriate medications to older veterans after participation in the Veterans Affairs (VA) Geriatric Scholars Program.



Chad Moretz, ScD

Latest:

Medical Policy Determinations for Pharmacogenetic Tests Among US Health Plans

This analysis demonstrated significant variability in medical policy determinations and evidence cited for clinically relevant pharmacogenetic tests among major US health insurers and laboratory benefit managers.


Colleen M. McCullough, MPA

Latest:

Patient-Centered Medical Home and Quality Measurement in Small Practices

Small practices with NCQA patient-centered medical home recognition perform better on quality measures, especially those related to chronic conditions.


Jason R. Goldsmith, MD, PhD

Latest:

5-ASA to Sulfasalazine Drug Switch Program in Patients With Ulcerative Colitis

A 5-aminosalicylic acid (5-ASA) drug switch program switching from 5-ASA to sulfasalazine was instituted for insured patients with ulcerative colitis. Unanticipated barriers limited the number of patients who switched, but significant cost savings were still obtained.


Amol D. Dhamane, BPharm, MS

Latest:

Outcomes Associated With Timing of Maintenance Treatment for COPD Exacerbation

Early initiation of maintenance medication in patients with moderate to severe COPD exacerbations is associated with reduced risk of future exacerbations and lower costs.


Patricia Sinnott, PhD

Latest:

Inappropriate Ordering of Lumbar Spine Magnetic Resonance Imaging: Are Providers Choosing Wisely?

This article analyzes use of lumbar spine magnetic resonance imaging in a national sample of patients with low back pain.



© 2025 MJH Life Sciences
AJMC®
All rights reserved.